Summary & Overview
CPT 57456: Colposcopy of Cervix with Endocervical Curettage
CPT code 57456 represents colposcopy of the cervix with endocervical curettage, a diagnostic gynecologic procedure used to evaluate abnormal cervical findings and obtain tissue from the endocervical canal. Nationally, this code is important for women's health services and preventive and diagnostic pathways related to cervical dysplasia and other abnormalities detected by screening.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and commonly reported modifiers. The publication outlines what providers and administrators need to know about billing practice patterns, coverage considerations from major payers, and common documentation elements tied to the procedure. It also summarizes typical service line placement for coding and revenue-cycle workflows.
This resource is intended to give clinicians, billers, and health policy professionals a clear baseline understanding of CPT code 57456, its clinical role in diagnosing cervical pathology, and the payer landscape relevant to national billing and coverage practices. Data not available in the input are noted where applicable.
Billing Code Overview
CPT code 57456 describes a diagnostic procedure in which a physician performs a colposcopic examination of the cervix, including the upper or adjacent portion of the vagina, and obtains tissue via endocervical curettage using a curette (spoon-shaped scraping instrument). This combines visual inspection with targeted sampling of the endocervical canal to evaluate abnormal cervical findings.
-
Service type: Colposcopy with endocervical curettage (diagnostic gynecologic procedure)
-
Typical site of service: Outpatient clinic, physician office, or ambulatory surgical center where gynecologic diagnostic procedures are performed.
Clinical & Coding Specifications
Clinical Context
A 32-year-old woman presents to an outpatient gynecology clinic after an abnormal screening Pap test showing high-grade squamous intraepithelial lesion (HSIL) on cytology. She reports intermittent postcoital spotting but no significant pelvic pain or fever. The clinician reviews prior records, obtains informed consent, and performs a focused pelvic exam. Using a colposcope, the physician inspects the cervix and the adjacent upper vagina with application of acetic acid and Lugol’s iodine to identify acetowhite lesions. Directed biopsies are taken from suspicious areas. Because the transformation zone is not fully visualized or to evaluate for possible endocervical pathology, the clinician performs endocervical curettage (ECC) with a curette to obtain tissue from the endocervical canal for histopathology. Specimens are labeled, submitted to pathology, and the patient is provided postprocedure care instructions and follow-up planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when an E/M visit is performed in addition to the colposcopy/ECC for a separate issue or for preprocedure evaluation beyond routine consent and brief assessment. |
26 |